 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase II Clinical Trial of Hyperbaric Oxygenation in Conjunction with Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastoma |
|
Mineola, NY USA |
|
06/18/2009 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Oceanside, NY USA |
|
05/20/2009 |
|
|
|
Details |
|
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
|
Bethesda, MD USA |
|
04/21/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Cincinnati, OH USA |
|
04/06/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Cincinnati, OH USA |
|
04/06/2009 |
|
|
|
|
|
Details |
|
RTOG 0424 A Phase II Study of Temozolomide-Based Chemoradiotherapy Regimen for High Risk Low-Grade Gliomas |
|
Cincinnati, OH USA |
|
04/06/2009 |
|
|
|
Details |
|
A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Back up Stereotactic Radiation Therapy |
|
Cincinnati, OH USA |
|
04/06/2009 |
|
|
|
|
|
Details |
|
Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
|
Houston, TX USA |
|
04/03/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Dallas, TX USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Tampa, FL USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Summit, NJ USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Cleveland, OH USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Los Angeles, CA USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Columbus, OH USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Chicago, IL USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Ann Arbor, MI USA |
|
03/15/2009 |
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Minneapolis, MN USA |
|
03/15/2009 |
|
|
|
|
|
Details |
|
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
|
Rochester, NY USA |
|
03/15/2009 |
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Durham, NC USA |
|
03/04/2009 |
|
|
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
New York, NY USA |
|
03/04/2009 |
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Tampa, FL USA |
|
03/04/2009 |
|
|
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Los Angeles, CA USA |
|
03/04/2009 |
|
|
|
Details |
|
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Omaha, NE USA |
|
03/04/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Chicago, IL USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Detroit, MI USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Los Angeles, CA USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Durham, NC USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
San Francisco, CA USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Charlottesville, VA USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Cleveland, OH USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Cleveland, OH USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Hackensack, NJ USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Syracuse, NY USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Chicago, IL USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Los Angeles, CA USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Boston, MA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Jacksonville, FL USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
New Haven, CT USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Buffalo, NY USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Salt Lake City, UT USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Columbus, OH USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Evanston, IL USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
New York, NY USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Palo Alto, CA USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
New York, NY USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Philadelphia, PA USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Houston, TX USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Iowa City, IA USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Seattle, WA USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
New York, NY USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
San Francisco, CA USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Saginaw, MI USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Gainsville, FL USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
San Antonio, TX USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Orange, CA USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Atlanta, GA USA |
|
01/31/2009 |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Baltimore, MD USA |
|
01/31/2009 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Lansing, MI USA |
|
01/31/2009 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Charlottesville, VA USA |
|
09/30/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Charlottesville, VA USA |
|
09/30/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Tampa, FL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Akron, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Cleveland, OH |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Springfield, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Goldsboro, NC USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Greenville, SC USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Akron, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Wynnewood, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Kingsport, TN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Newark, DE USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Philadelphia, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Mobile, AL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Loma Linda, CA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Sacramento, CA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Pomona, CA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Sacramento, CA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Lewes, DE USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Newark, DE USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Jacksonville, FL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, GA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Honolula, HI USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Boise, ID USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Maywood, IL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Harvey, IL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Chicago, IL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
South Bend,, IN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
South Bend, IN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Annapolis, MD USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Detroit, MI USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Royal Oak, MI USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Saint Louis Park, MN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Edina, MN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Robbinsdale, MN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Minneapolis, MN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Cape Girardeau, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Kansas City, MO USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Saint Louis, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
St Louis, MO USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Joplin, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Omaha, NE USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Concord, NH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Lebanon, NH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Voorhees, NJ USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Marlton, NJ USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Toms River, NJ USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Long Branch,, NJ USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Syracuse, NY USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Rochester, NY USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Minot, ND USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Chillicothe, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Akron, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Canton, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Wooster, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Zanesville, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Tulsa, OK USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Bryn Mawr, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Philadelphia, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Philadelphia, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Allentown, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Paoli, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Reading, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Bethlehem, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Greenville, SC USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Charleston, SC USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Rapid City, SD USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Kingsport, TN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Temple, TX USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Lubbock, TX USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Galveston, TX USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Murray, UT USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Saint George, UT USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Salt Lake City, UT USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Ogden, UT USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Provo, UT USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Burlington, VT USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Yakima, WA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Bellingham, WA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Racine, WI USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Menomonee Falls, WI USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
La Crosse, WI USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Milwaukee, WI USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Green Bay, WI USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Madison, WI USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery |
|
Durham, NC USA |
|
03/02/2008 |
|
|
|
Details |
|
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
|
Baltimore, MD USA |
|
08/31/2007 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
|
Duarte, CA USA |
|
08/31/2007 |
|
|
|
Details |
|
A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients |
|
Toronto, Ontario, CANADA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas |
|
Bergen, Norway |
|
08/26/2007 |
|
|
|
Details |
|
Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status |
|
Boston, MA USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
08/26/2007 |
|
|
|
Details |
|
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
|
Charleston, SC USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
08/26/2007 |
|
|
|
Details |
|
A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
|
Vista, CA USA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Boston, MA USA |
|
08/19/2007 |
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Los Angeles, CA USA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Boston, MA USA |
|
08/19/2007 |
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Boston, MA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
New York, NY USA |
|
08/19/2007 |
|
|
|
Details |
|
Gliadel and Dendritic Cell Vaccine for Malignant Glioma |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Dendritic Cell Vaccine Pulsed with Tumor Lysate Followed by Temozolomide Upon Recurrence in Patients with Newly Diagnosed Glioblastoma |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Atlanta, GA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Washington, DC USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Orange, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
St. Petersburg, FL USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
West Palm Beach, FL USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Kansas City, MO USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Paterson, NJ USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Summit, NJ USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
New York, NY USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Columbus, OH USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Roanoke, VA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Perth, Western Australia, 6001, Australia |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Hamilton, Canada |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Charleston, WV USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
San Antonio, TX USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Sacramento, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Pittsburgh, PA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Indianapolis, IN USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Charlotte, NC USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Oklahoma City, OK USA |
|
08/18/2007 |
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Philadelphi, PA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Stereotactic Radiosurgery for Metastatic Brain Tumors |
|
Hackensack, NJ USA |
|
08/18/2007 |
|
|
|
Details |
|
Phase 1 Trial Gamma Knife For Primary Brain Tumors - Gliomas. |
|
Birmingham, AL USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Chicago, IL USA |
|
06/04/2007 |
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Birmingham, AL USA |
|
06/04/2007 |
|
|
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Cambridge, MA USA |
|
06/04/2007 |
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Grand Rapids, MI USA |
|
06/04/2007 |
|
|
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Dallas, TX USA |
|
06/04/2007 |
|
|
|
Details |
|
A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
|
Cincinnati , OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases |
|
Chapel Hill, NC USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Boston, MA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Rochester, MN USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Jacksonville, FL USA |
|
05/01/2007 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Tampa, FL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Winston-Salem, NC USA |
|
05/01/2007 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Detroit, MI USA |
|
05/01/2007 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Baltimore, MD USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Birmingham, AL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Detroit, MI USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Madison, WI USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Phoenix, AZ USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
New Haven, CT USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Springfield, MO USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Goldsboro, NC USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Portland, OR USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Greenville, SC USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Rochester, MN USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Kalamazoo, MI USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Lambertville, MI USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Saint Louis Park, MN USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Lewes, DE USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Columbus, GA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Dubuque, IA USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Omaha, NB USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Lebanon, NH USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Albuquerque, NM USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Buffalo, NY USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Akron, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Tulsa, OK USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Wynnewood, PA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Kingsport, TN USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Salt Lake City, UT USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Jacksonville, FL USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Fort Lauderdale, FL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Miami, FL USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Long Branch, NJ USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Mount Holly, NJ USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Utica, NY USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Rochester, MN USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Jacksonville, FL USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Phoenix, AZ USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Kalamazoo, MI USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Saint Louis Park, MN USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Columbus, GA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Dubuque, IA USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Akron, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Salt Lake City, UT USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Manhasset, NY USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Newark, DE USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Orlando, FL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Boise, ID USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Harvey, IL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Hammond, IN USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Las Vegas, NV USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Philadelphia, PA USA |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Richmond, VA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Milwaukee, WI USA |
|
05/01/2007 |
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Tampa, FL USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Winston-Salem, NC USA |
|
04/29/2007 |
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Boston, MA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Baltimore, MD USA |
|
04/29/2007 |
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Atlanta, GA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Birmingham, AL USA |
|
04/29/2007 |
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Philadelphia, PA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Detroit, MI USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Birmingham, AL USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Phoenix, AZ USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Cleveland, OH USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Phoenix, AZ USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Los Angeles, CA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Long Beach, CA USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Sacramento, CA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
St. Petersburg, FL USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Jacksonville, FL USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
West Palm Beach, FL USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Augusta, GA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Honolulu, HI USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Chicago, IL USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Park Ridge, IL USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Iowa City, IA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Scarborough, ME USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Baltimore, MD USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Boston, MA USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Grand Rapids, MI USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Saint Louis, MO USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Kansas City, MO USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Saint Louis, MO USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Omaha, NE USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Las Vegas, NV USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Hackensack, NJ USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Summit, NJ USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Brooklyn, NY USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Rochester, NY USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
New York, NY USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Valhalla, NY USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
New Hyde Park, NY USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Dayton, OH USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Cleveland, OH USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Knoxville, TN USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Memphis, TN USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Houston, TX USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Fort Worth, TX USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Lubbock, TX USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Dallas, TX USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
San Antonio, TX USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Burlington, VT USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Roanoke, VA USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Falls Church, VA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Huntington, WV USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Milwaukee, WI USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Downey, CA USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Atlanta, GA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Denver, CO USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Pittsburgh, PA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
New Orleans, LA USA |
|
04/29/2007 |
|
|
|
Details |
|
A Randomized, Open-Label Phase 3 Study of Temozolomide Added to Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone for the Treatment of Brain Metastasis From Non-Small Cell Lung Cancer |
|
Los Angeles, CA USA |
|
04/27/2007 |
|
|
|
|
|
Details |
|
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma |
|
Villejuif, France |
|
04/15/2007 |
|
|
|
Details |
|
Erlotinib (Tarceva) Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma |
|
Dublin, USA |
|
04/15/2007 |
|
|
|
|
|
Details |
|
A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme |
|
Detroit, MI USA |
|
11/05/2006 |
|
|
|
Details |
|
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Des Moines, IA USA |
|
08/11/2006 |
|
|
|
|
|
Details |
|
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Jacksonville, FL USA |
|
08/11/2006 |
|
|
|
Details |
|
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Scottsdale/Phoenix, AZ USA |
|
08/11/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Wichita, KS USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Urbana, IL USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Peoria, IL USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Cedar Rapids, IA USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Des Moines, IA USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Sioux City, IA USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Saint Cloud, MN USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Fargo, ND USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Birmingham, AL USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Moline, IL USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Missouri Valley, IA USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Lincoln, NE USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Bismarck, ND USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Allentown, PA USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Rochester, MN USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Jacksonville, FL USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Scottsdale/Phoenix, AZ USA |
|
06/26/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Little Rock, AR USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Jacksonville, FL USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Honolulu, HI USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Boise, ID USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Chicago, IL USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Peoria, IL USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Boston, MA USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Kalamazoo, MI USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Grand Rapids, MI USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Kansas City, MO USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Saint Louis, MO USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Las Vegas, NV USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Summit, NJ USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
New York, NY USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Valhalla, NY USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Dayton, OH USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Columbus, OH USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Cleveland, OH USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Nashville, TN USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Fort Worth, TX USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Amarillo, TX USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Huntington, WV USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Perth, Western Australia, 6001, Australia |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
, Canada |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
, Canada |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Charleston, WV USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Downey, CA USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Phoenix, AZ USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Lebanon, NH USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Charleston, SC USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Pittsburgh, PA USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Boston, MA USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Farmington, CT USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Orlando, FL USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Pensacola, FL USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Gainesville, FL USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Miami, FL USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Indianapolis, IN USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Indianapolis, IN USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Kansas City, KS USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Louisville, KY USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Bangor, ME USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Detroit, MI USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Rochester, MN USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Jackson, MS USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
New Brunswick, NJ USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Albuquerque, NM USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Syracuse, NY USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Charlotte, NC USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Cincinnati,, OH USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Oklahoma City, OK USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Hershey, PA USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Columbia, SC USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Corpus Christi, TX USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Dallas, TX USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Salt Lake City, UT USA |
|
05/30/2006 |
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Spokane, WA USA |
|
05/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Phoenix, AZ USA |
|
05/29/2006 |
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Jacksonville, FL USA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Akron, OH USA |
|
05/29/2006 |
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Murray, UT USA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Saint George, UT USA |
|
05/29/2006 |
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Ogden, UT USA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Provo, UT USA |
|
05/29/2006 |
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Kearney, NE USA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Vineland, NJ USA |
|
05/29/2006 |
|
|
|
Details |
|
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
|
Wheeling, WV USA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion |
|
Louisville, KY USA |
|
05/27/2006 |
|
|
|
Details |
|
A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour |
|
Edmonton, Alberta, Canada |
|
05/04/2006 |
|
|
|
|
|
Details |
|
Treatment of Primary Glioblastoma Multiforme With Cetuximab (Erbitux), Radiotherapy and Temozolomide (GERT) – Phase I/II Trial |
|
Heidelberg, Baden-Württemberg, Germany |
|
05/04/2006 |
|
|
|
Details |
|
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
|
Durham, NC USA |
|
05/02/2006 |
|
|
|
|
|
Details |
|
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
|
Memphis, TN USA |
|
05/02/2006 |
|
|
|
Details |
|
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
|
Houston, TX USA |
|
05/02/2006 |
|
|
|
|
|
Details |
|
Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504) |
|
Yamagata, Japan |
|
04/30/2006 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Detroit, MI USA |
|
02/03/2006 |
|
|
|
|
|
Details |
|
Iodine I 131 Monoclonal Antibody TNT-1/B (131I MOAB TNT-1/B), in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
|
Detroit, MI USA |
|
02/03/2006 |
|
|
|
Details |
|
Phase I/II Study of Concurrent Dose Escalation Temodar and Whole Brain Radiation Therapy in Patients with Multiple Brain Metastases.
|
|
Detroit, MI USA |
|
02/03/2006 |
|
|
|
|
|
Details |
|
Phase II Study Utilizing Focal Radiation in Patients with 1-3 Brain Metastases.
|
|
Detroit, MI USA |
|
02/03/2006 |
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
, Austria |
|
01/08/2006 |
|
|
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
Toronto, Ontario, Canada |
|
01/08/2006 |
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
Nice, 06002, France |
|
01/08/2006 |
|
|
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
Munich, D-81377, Germany |
|
01/08/2006 |
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
Pisa, 56100, Italy |
|
01/08/2006 |
|
|
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
Petten, NL-1755 ZG, Netherlands |
|
01/08/2006 |
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
Amsterdam, 1007 MB, Netherlands |
|
01/08/2006 |
|
|
|
|
|
Details |
|
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
|
ESSEN, Germany |
|
01/08/2006 |
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Edison, NJ USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Smithtown, NY USA |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated Streotactic Rdaiotherapy boost and Temozolamide in malignant Gliomas |
|
Brooklyn, NY USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Stereotactic Radiosurgery VS. Conventional Radiotherapy for Recurrent / Invasive Pituitary Tumors |
|
Hackensack, NJ USA |
|
12/03/2005 |
|
|
|
Details |
|
Treatment of newly diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor (PNET), or Atypical Teratoid Rhabdoid Tumor (ATRT) |
|
Memphis, TN USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors |
|
La Jolla, CA USA |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy. |
|
New York, NY USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
|
Rockville Centre, NY USA |
|
12/03/2005 |
|
|
|
Details |
|
Pilot study of systemic and intrathecal chemotherapy followed by conformal radiation for infants with embryonal intracranial central nervous system tumors. |
|
Durham, NC USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Mobile , AL |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas, meningiomas and metastatic brain tumors. |
|
New York, NY USA |
|
12/03/2005 |
|
|
|
|
